ArticleInternational journal of clinical and experimental pathology2015

Reduced beta 2 glycoprotein I improves diabetic nephropathy via inhibiting TGF-β1-p38 MAPK pathway.

Tong Wang et al.PubMed ↗Full text ↗

No numbers read from the abstract.